1 / 12

The 2013 South African Bioeconomy Strategy

The 2013 South African Bioeconomy Strategy. Jennifer A Thomson Dept Molecular and Cell Biology University of Cape Town South Africa. National Biotechnology Strategy 2001. Biotechnology Innovation Centres (BICs) National Biotechnology Advisory Committee

delila
Télécharger la présentation

The 2013 South African Bioeconomy Strategy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The 2013 South African Bioeconomy Strategy Jennifer A Thomson Dept Molecular and Cell Biology University of Cape Town South Africa

  2. National Biotechnology Strategy 2001 • Biotechnology Innovation Centres (BICs) • National Biotechnology Advisory Committee • Govt articulate single policy position on biotech • Took 10 people 2 weeks (with many interviews) • Approved (with payment via President) BUT single policy never occurred

  3. Biotechnology (Regional) Innovation Centres • LIFElab (KZN) amino acids, bioprocessing • BioPAD (JHB)  animal vaccines, diagnostics, health • Cape Biotech  health care, algal tech • PlantBio  plant biotechnology

  4. Biotechnology Advisory Committee • GMO Act – time frames (still on table) • Consumer Protection Act - labelling • Biotech company failures – revisiting • Many problems due to >> DST (Agric., Environ., T and I) – no buy in • Technology Innovation Agency (TIA) – warned of impending disaster  2008 dissolved BICs  investigation

  5. Bioeconomy Strategy 2013 • Committee(s)  5 years • Bioeconomy > Biotechnology • Activities using bio-innovations  sustainable economic, social, environmental development • “DST as lead agent to work with other depts. Will drive consultative process”

  6. Innovation Pipeline (non-linear) • Concept/idea – National Research Foundation (NRF) • Research – NRF • Development - ?? GAP! Many small companies fold here • Productisation – TIA • Manufacturing – TIA • Commercialisation – TIA

  7. Highlights of the Strategy • Venture Capital fund – public/private facilitated by DST – use govt funds to attract private capital • Alignment of regulations and legislation • Communication and marketing • Agriculture, health and industry /environment sectors

  8. Agriculture • “Responsible genetic engineering remains a critical technology.. and presents a significant competitive opportunity..” • Of three sectors this has “highest economic impact.” • “Expanded R&D essential..” • Animal vaccines highlighted • Development of ‘energy crops’

  9. Health • Vaccines esp. TB and HIV – all imported • Diagnostics esp. TB and HIV • Medical devices – 80-90% imported • Biodiscovery • Indigenous knowledge

  10. Industry and Environment • Enzyme manufacturing (all imported) • Biofuels • Wastewater treatment • Bioprospecting (biodiscovery) – SA 3rd most biologically diverse country

  11. Legislation needing change • Consumer Protection Act – labelling “may contain genetically modified ingredients” • GMO Act – time frames not complied with (eg. appeals 180 d max  > 2 yrs) • Biodiversity Act – who are the ‘knowledge holders’? • TIA Act – equity holder, M&E, implementation (skills, relationships..) • Labour Act – millstones eg. employment and firing, company registrations…

  12. Implementation • Driven by DST • July high-level meeting with private sector, other govtdepts, research institutions… • Legislation problems  meetings with DGs various depts. • NBAC + Minister 16 August • Report back ICABR 2014 (Nairobi??)

More Related